Regulation of basal myocardial function by NO - PubMed (original) (raw)
Review
Regulation of basal myocardial function by NO
G Kojda et al. Cardiovasc Res. 1999 Mar.
Abstract
The effects of exogenous and endogenous. NO on myocardial functions such as contraction, relaxation and heart rate have recently gained considerable scientific interest. .NO stimulates myocardial soluble guanylate cyclase to produce cGMP, which activates two major target proteins. A small increase in cGMP levels predominantly inhibits phosphodiesterase III, while high cGMP levels activate cGMP-dependent protein kinase. Accordingly, submicromolar .NO concentrations improve myocardial contraction, while submillimolar .NO concentrations decrease contractility. The latter action includes direct inhibitory .NO effects on ATP synthesis and voltage-gated calcium channels. Overall, the inotropic effects of exogenous .NO are small and probably of minor importance for myocardial contractility. Cardiomyocytes are capable of expressing eNOS and iNOS. Endogenous .NO has effects on myocardial contraction, similar to that of exogenous .NO. Various NOS inhibitors can substantially reduce myocardial contractility in vitro and in vivo, suggesting that basal endogenous .NO production supports myocardial contractility. There is also evidence for a .NO-dependent cardiodepressive effect of cytokines that is mediated by expression of iNOS. This is consistent with the negative inotropic effects of .NO at high concentrations. Cardiodepressive actions of endogenous .NO production may play a role in certain forms of heart failure. Finally, .NO also has an effect on heart rate. Physiologic .NO concentrations can stimulate heart rate by activating the hyperpolarization-activated inward current (If) and this effect decreases at submillimolar .NO concentrations. In summary, physiological concentrations of .NO increase contractility and heart rate under basal conditions, while high .NO concentrations induce the opposite effects.
Comment in
- Regulation of basal myocardial function by NO.
Pagliaro P. Pagliaro P. Cardiovasc Res. 1999 Oct;44(1):223-4. doi: 10.1016/s0008-6363(99)00208-4. Cardiovasc Res. 1999. PMID: 10615406 No abstract available.
Similar articles
- The nitric oxide donors, SNAP and DEA/NO, exert a negative inotropic effect in rat cardiomyocytes which is independent of cyclic GMP elevation.
Sandirasegarane L, Diamond J. Sandirasegarane L, et al. J Mol Cell Cardiol. 1999 Apr;31(4):799-808. doi: 10.1006/jmcc.1998.0919. J Mol Cell Cardiol. 1999. PMID: 10329207 - Differential regulation of the nitric oxide-cGMP pathway exacerbates postischaemic heart injury in stroke-prone hypertensive rats.
Itoh T, Haruna M, Abe K. Itoh T, et al. Exp Physiol. 2007 Jan;92(1):147-59. doi: 10.1113/expphysiol.2006.035097. Epub 2006 Oct 9. Exp Physiol. 2007. PMID: 17030559 - The negative inotropic effect of beta3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle.
Gauthier C, Leblais V, Kobzik L, Trochu JN, Khandoudi N, Bril A, Balligand JL, Le Marec H. Gauthier C, et al. J Clin Invest. 1998 Oct 1;102(7):1377-84. doi: 10.1172/JCI2191. J Clin Invest. 1998. PMID: 9769330 Free PMC article. - Nitric oxide-cyclic GMP pathway with some emphasis on cavernosal contractility.
Ghalayini IF. Ghalayini IF. Int J Impot Res. 2004 Dec;16(6):459-69. doi: 10.1038/sj.ijir.3901256. Int J Impot Res. 2004. PMID: 15229623 Review. - Role of nitric oxide in the regulation of myocardial function.
Hare JM, Colucci WS. Hare JM, et al. Prog Cardiovasc Dis. 1995 Sep-Oct;38(2):155-66. doi: 10.1016/s0033-0620(05)80004-0. Prog Cardiovasc Dis. 1995. PMID: 7568904 Review.
Cited by
- Inhibition of nitric oxide synthase enhances contractile response of ventricular myocytes from streptozotocin-diabetic rats.
Smith JM, Sondgeroth KB, Wahler GM. Smith JM, et al. Mol Cell Biochem. 2007 Jun;300(1-2):129-37. doi: 10.1007/s11010-006-9376-3. Epub 2007 Jan 16. Mol Cell Biochem. 2007. PMID: 17225190 - Nitric oxide donor, NOC7, reveals biphasic effect on contractile force of isolated rat heart after global ischemia.
Hui Y, Mochizuki T, Kondo K, Umemura K, Sato S. Hui Y, et al. J Anesth. 2008;22(3):229-35. doi: 10.1007/s00540-008-0625-3. Epub 2008 Aug 7. J Anesth. 2008. PMID: 18685928 - 17β-Estradiol mediates superior adaptation of right ventricular function to acute strenuous exercise in female rats with severe pulmonary hypertension.
Lahm T, Frump AL, Albrecht ME, Fisher AJ, Cook TG, Jones TJ, Yakubov B, Whitson J, Fuchs RK, Liu A, Chesler NC, Brown MB. Lahm T, et al. Am J Physiol Lung Cell Mol Physiol. 2016 Aug 1;311(2):L375-88. doi: 10.1152/ajplung.00132.2016. Epub 2016 Jun 10. Am J Physiol Lung Cell Mol Physiol. 2016. PMID: 27288487 Free PMC article. - NO Better Way to Protect the Heart during Ischemia-Reperfusion: To be in the Right Place at the Right Time.
Farah C, Reboul C. Farah C, et al. Front Pediatr. 2015 Feb 6;3:6. doi: 10.3389/fped.2015.00006. eCollection 2015. Front Pediatr. 2015. PMID: 25705614 Free PMC article. Review. No abstract available. - Alcohol in moderation, cardioprotection, and neuroprotection: epidemiological considerations and mechanistic studies.
Collins MA, Neafsey EJ, Mukamal KJ, Gray MO, Parks DA, Das DK, Korthuis RJ. Collins MA, et al. Alcohol Clin Exp Res. 2009 Feb;33(2):206-19. doi: 10.1111/j.1530-0277.2008.00828.x. Epub 2008 Nov 19. Alcohol Clin Exp Res. 2009. PMID: 19032583 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources